XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.780
+0.018 (0.65%)
At close: Aug 21, 2026, 4:00 PM EDT
2.660
-0.120 (-4.32%)
After-hours: Aug 21, 2026, 7:15 PM EDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $6.58 million as of August 21, 2026. Its market cap has decreased by -43.41% in one year.
Market Cap
6.58M
Enterprise Value
6.50M
1-Year Change
-43.41%
Ranking
Category
Stock Price
$2.78
ChartMarket Cap Chart
Since September 1, 2005, XTL Biopharmaceuticals's market cap has decreased from $190.39M to $6.58M, a decrease of -96.55%. That is a compound annual growth rate of -14.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 6.58M | -7.67% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curanex Pharmaceuticals | 7.39M |
| Bolt Biotherapeutics | 7.06M |
| Liminatus Pharma | 6.93M |
| Kairos Pharma | 6.87M |
| NuCana | 6.55M |
| Enveric Biosciences | 6.40M |
| Purple Biotech | 6.25M |
| Ensysce Biosciences | 6.06M |